Literature DB >> 33549076

Ursolic acid induces apoptosis and anoikis in colorectal carcinoma RKO cells.

Jia-Lu Zheng1,2, Shuang-Shuang Wang3, Ke-Ping Shen2, Lei Chen1,2, Xiao Peng1,2, Jin-Fang Chen1,2, Hong-Mei An4, Bing Hu5,6.   

Abstract

BACKGROUND: Ursolic acid (UA) is an anti-cancer herbal compound. In the present study, we observed the effects of UA on anchorage-dependent and -independent growth of human colorectal cancer (CRC) RKO cells.
METHODS: RKO cells were cultured in conventional and detached condition and treated with UA. Cell viability was evaluated by CCK-8 assay. Cell cycle was analyzed by flow cytometry. Apoptosis was identified by Hoechst 33258 staining and flow cytometry analysis. Activities of caspases were measured by commercial kits. Reactive oxygen species (ROS) was recognized by DCFH-DA fluorescent staining. Anoikis was identified by EthD-1 fluorescent staining and flow cytometry analysis. Expression and phosphorylation of proteins were analyzed by western blot.
RESULTS: UA inhibited RKO cell viability in both a dose- and time-dependent manner. UA arrested the cell cycle at the G0/G1 phase, and induced caspase-dependent apoptosis. UA inhibited Bcl-2 expression and increased Bax expression. In addition, UA up-regulated the level of ROS that contributed to UA activated caspase-3, - 8 and - 9, and induced apoptosis. Furthermore, UA inhibited cell growth in a detached condition and induced anoikis in RKO cells that was accompanied by dampened phosphorylation of FAK, PI3K and AKT. UA also inhibited epithelial-mesenchymal transition (EMT) as indicated by the down-regulation of N-Cad expression and up-regulation of E-Cad expression.
CONCLUSIONS: UA induced caspase-dependent apoptosis, and FAK/PI3K/AKT singling and EMT related anoikis in RKO cells. UA was an effective anti-cancer compound against both anchorage-dependent and -independent growth of RKO cells.

Entities:  

Keywords:  AKT; Anoikis; Apoptosis; Caspases; Colorectal cancer; Epithelial-mesenchymal transition; FAK; PI3K; Reactive oxygen species; Ursolic acid

Year:  2021        PMID: 33549076     DOI: 10.1186/s12906-021-03232-2

Source DB:  PubMed          Journal:  BMC Complement Med Ther        ISSN: 2662-7671


  1 in total

1.  Ursolic Acid Inhibits Epithelial-Mesenchymal Transition through the Axl/NF-κB Pathway in Gastric Cancer Cells.

Authors:  Jinxia Li; Chunyan Dai; Li Shen
Journal:  Evid Based Complement Alternat Med       Date:  2019-06-09       Impact factor: 2.629

  1 in total
  1 in total

1.  Cancer Cell Inhibiting Sea Cucumber (Holothuria leucospilota) Protein as a Novel Anti-Cancer Drug.

Authors:  Ruizhen Ru; Yanzheng Guo; Juanxuan Mao; Zonghe Yu; Wen Huang; Xudong Cao; Huijian Hu; Minjie Meng; Lihong Yuan
Journal:  Nutrients       Date:  2022-02-13       Impact factor: 5.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.